TFE3 Protein

TFE3 Protein

Overview

TFE3 protein (Transcription Factor Binding to IGHM Enhancer 3) is a basic helix-loop-helix leucine zipper (bHLH-LZ) transcription factor encoded by the [TFE3](/genes/tfe3) gene. As a member of the MiT/TFE family alongside [TFEB](/genes/tfeb) and [MITF](/genes/mitf), TFE3 functions as a master regulator of lysosomal biogenesis, [autophagy](/entities/autophagy), and cellular stress responses by binding Coordinated Lysosomal Expression and Regulation (CLEAR) elements in target gene promoters. Its nuclear-cytoplasmic shuttling is controlled by [mTORC1](/genes/mtor)-dependent phosphorylation, and disruption of this regulation contributes to lysosomal dysfunction in [Alzheimer's disease](/diseases/alzheimers-disease), [Parkinson's disease](/diseases/parkinsons-disease), and [Huntington's disease](/diseases/huntington-disease).

TFE3 Protein

Overview

TFE3 protein (Transcription Factor Binding to IGHM Enhancer 3) is a basic helix-loop-helix leucine zipper (bHLH-LZ) transcription factor encoded by the [TFE3](/genes/tfe3) gene. As a member of the MiT/TFE family alongside [TFEB](/genes/tfeb) and [MITF](/genes/mitf), TFE3 functions as a master regulator of lysosomal biogenesis, [autophagy](/entities/autophagy), and cellular stress responses by binding Coordinated Lysosomal Expression and Regulation (CLEAR) elements in target gene promoters. Its nuclear-cytoplasmic shuttling is controlled by [mTORC1](/genes/mtor)-dependent phosphorylation, and disruption of this regulation contributes to lysosomal dysfunction in [Alzheimer's disease](/diseases/alzheimers-disease), [Parkinson's disease](/diseases/parkinsons-disease), and [Huntington's disease](/diseases/huntington-disease).

<div class="infobox infobox-protein"> [@settembre2011]
<div class="infobox-header">TFE3 Protein</div> [@pastore2017]
<table> [@decressac2013]
<tr><td class="infobox-label">Protein Name</td><td>Transcription factor E3</td></tr> [@sardiello2009]
<tr><td class="infobox-label">Gene</td><td>[TFE3](/genes/tfe3)</td></tr> [@roczniakferguson2012]
<tr><td class="infobox-label">UniProt ID</td><td>[P19532](https://www.uniprot.org/uniprot/P19532)</td></tr> [@bordi2016]
<tr><td class="infobox-label">PDB IDs</td><td>[2H9D](https://www.rcsb.org/structure/2H9D)</td></tr>
<tr><td class="infobox-label">Molecular Weight</td><td>59.5 kDa</td></tr>
<tr><td class="infobox-label">Subcellular Localization</td><td>Cytoplasm (inactive), Nucleus (active)</td></tr>
<tr><td class="infobox-label">Protein Family</td><td>MiT/TFE family (bHLH-LZ)</td></tr>
<tr><td class="infobox-label">Associated Diseases</td><td>[AD](/diseases/alzheimers-disease), [PD](/diseases/parkinsons-disease), [HD](/diseases/huntingtons-disease), Xp11 translocation RCC</td></tr>
</table>
</div>

Structure

Domain Architecture

• Activation domain (N-terminal, residues 1-120): Transactivation region that recruits coactivators including CBP/p300
• Glutamine-rich region (residues 121-200): Additional transactivation surface
• Basic region (residues 261-280): DNA-binding domain that recognizes E-box (CANNTG) and CLEAR (GTCACGTGAC) motifs
• Helix-loop-helix domain (residues 281-330): Dimerization interface for homo- and heterodimerization with [TFEB](/entities/tfeb), MITF, and TFEC
• Leucine zipper (residues 331-370): Extended coiled-coil for stable dimer formation
• Regulatory region (C-terminal, residues 371-575): Contains mTORC1 phosphorylation sites (Ser321) and 14-3-3 binding motifs

Phosphorylation-Dependent Regulation

• Active mTORC1 phosphorylates TFE3 at Ser321 (and additional sites Ser246, Ser247)
• Phospho-Ser321 creates a high-affinity 14-3-3 binding site
• 14-3-3 binding masks the nuclear localization signal (NLS), retaining TFE3 in the cytoplasm
• Lysosomal stress / starvation: Calcineurin (activated by lysosomal Ca2+ release via MCOLN1/TRPML1) dephosphorylates Ser321
• Dephosphorylated TFE3 translocates to the nucleus and activates CLEAR element-containing genes

Dimerization

• TFE3-TFE3 homodimers: Most common form; strong CLEAR element affinity
• TFE3-TFEB heterodimers: Function cooperatively on shared target genes
• TFE3-MITF heterodimers: Primarily in melanocytes and microglial cells
• Dimerization is required for DNA binding and transcriptional activity

Normal Function

Master Regulator of Lysosomal Biogenesis

• Over 400 direct transcriptional targets with CLEAR elements
• Coordinates lysosomal enzyme production, membrane protein insertion, and acidification
• Upregulates lysosomal exocytosis machinery for cellular clearance
• Activates lipophagy genes for lipid droplet catabolism

Autophagy Transcriptional Program

• Initiation: [ULK1](/genes/ulk1), ULK2, FIP200, ATG13
• Nucleation: [BECN1](/genes/becn1), VPS34, [ATG14](/genes/atg14)
• Elongation: ATG5, [ATG7](/genes/atg7), ATG12, LC3/GABARAP
• Cargo recognition: [SQSTM1/p62](/genes/sqstm1), [NBR1](/genes/nbr1), [OPTN](/genes/optn), TAX1BP1
• Fusion and degradation: STX17, VAMP8, lysosomal hydrolases

Nutrient Sensing and Metabolic Adaptation

• Starvation activates TFE3, promoting autophagy for nutrient recycling
• TFE3 induces oxidative metabolism genes including PGC-1α targets
• In the brain, TFE3 helps [neurons](/entities/neurons) adapt to metabolic stress by enhancing lysosomal capacity

Role in Disease

Alzheimer's Disease

• mTORC1 hyperactivation (driven by [Aβ](/proteins/amyloid-beta) and [tau](/proteins/tau)) traps TFE3 in the cytoplasm
• TFE3 nuclear levels are reduced in hippocampal neurons of AD patients
• Constitutively active TFE3 (S321A) reduces amyloid plaque burden in [APP](/entities/app-protein)/PS1 mice by ~40%
• TFE3 activation enhances lysosomal degradation of both Aβ and phospho-[tau](/proteins/tau)
• Combined TFE3/TFEB activation shows greater benefit than either alone

Parkinson's Disease

• [α-Synuclein](/proteins/alpha-synuclein) aggregates impair lysosomal acidification and trap TFE3 in the cytoplasm
• [GBA1](/genes/gba1) mutations reduce glucocerebrosidase activity, activating TFE3 as compensation (insufficient in disease)
• [LRRK2](/proteins/lrrk2-protein) G2019S increases mTORC1 activity, suppressing TFE3 nuclear translocation
• AAV-TFE3 gene therapy in dopaminergic neurons attenuates α-synuclein toxicity in rat PD models

Huntington's Disease

• Mutant [huntingtin](/proteins/huntingtin-protein) physically sequesters TFE3 in cytoplasmic aggregates
• TFE3 activation through trehalose or mTORC1 inhibition reduces polyQ aggregation
• Combined TFEB/TFE3 double activation clears mutant [huntingtin](/proteins/huntingtin) more effectively than single activation

Lysosomal Storage Disorders with Neurodegeneration

Therapeutic Targeting

• mTORC1 inhibitors: Rapamycin, Torin1 promote TFE3 nuclear translocation
• Trehalose: [mTOR](/mechanisms/mtor-signaling-pathway)-independent TFE3/TFEB activator with neuroprotective effects
• TRPML1/MCOLN1 agonists: ML-SA1, SF-51 activate calcineurin-dependent TFE3 dephosphorylation
• AAV-TFE3 gene therapy: Direct overexpression in target neurons; in preclinical testing
• TFE3-S321A variant: Constitutively nuclear, bypasses mTORC1 regulation

See Also

• [TFE3 Gene](/genes/tfe3)
• [TFEB](/genes/tfeb) — closely related family member
• [Autophagy-Lysosomal Pathway](/mechanisms/autophagy-lysosomal-pathway)
• [mTOR Signaling](/mechanisms/mtor-signaling-neurodegeneration)
• [LAMP1](/genes/lamp1) / [LAMP2](/genes/lamp2) — lysosomal markers

External Links

• [UniProt: P19532](https://www.uniprot.org/uniprot/P19532)
• [PDB: 2H9D](https://www.rcsb.org/structure/2H9D)
• [GeneCards: TFE3](https://www.genecards.org/cgi-bin/carddisp.pl?gene=TFE3)

References